MedPath

Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis

Recruiting
Conditions
Teleradiology
Hepatitis
Interventions
Device: TUP ultraportable US with teleradiology capacities
Device: CUS conventional ultrasound
Registration Number
NCT06571981
Lead Sponsor
Naik Vietti Violi
Brief Summary

Comparison of abdominal US exam in patients with viral hepatitis between ultraportable US with teleradiology capacities (TUP) versus conventional ultrasound (CUS)

Detailed Description

Primary Objective The investigation seeks primarily to determine the performance of abdominal US examinations realized with TUP and CUS based on defined imaging criteria Secondary Objectives Evaluate satisfaction and comfort and reproducibility of use of the ultraportable US

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Informed Consent signed by the subject
  • All adult patients with viral hepatitis for which an ultrasound is planned
Exclusion Criteria
  • Known or suspected non-compliance
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
  • Previous enrollment into the current study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with viral hepatitisTUP ultraportable US with teleradiology capacitiesEvery outpatient referred to the radiology department by a prescriber for abdominal US in the context of viral hepatitis
Patients with viral hepatitisCUS conventional ultrasoundEvery outpatient referred to the radiology department by a prescriber for abdominal US in the context of viral hepatitis
Primary Outcome Measures
NameTimeMethod
Comparison of TUP versus CUS for abdominal imaging in patients with viral hepatitis according to US LI-RADS categories ) for liver lesionsAt the end of intervention

LI RADS categories

No observation OR Only definitely benign observation(s) Observation(s) \< 10 mm in diameter, not definitely benign Observation(s) ≥ 10 mm in diameter, not definitely benign OR New thrombus in vein

Secondary Outcome Measures
NameTimeMethod
focal lesionsAt the end of intervention

Yes/No

liver visualization scoresAt the end of intervention

no or minimal limitations; moderate limitations; severe limitations

examination timeAt the end of intervention

minutes

video qualityAt the end of intervention

Adequate/Non Adequate

liver surface nodularityAt the end of intervention

Yes/No

caudate lobe dimensionsAt the end of intervention

cm

biliary tract / gallbladder abnormalitiesAt the end of intervention

Yes/No

lymph nodes presenceAt the end of intervention

Yes/No

free fluidAt the end of intervention

Yes/No

audio qualityAt the end of intervention

Adequate/Non Adequate

portal flow velocityAt the end of intervention

cm/s

agreement rates between reportsAt the end of intervention

Category 1: complete agreement/matching with teleradiologists reports; Category 2: minor discrepancy that would not impact patient management which included hedging terminology and ambiguous differences, for example fatty versus moderate fatty liver; Category 3: major discrepancy that would likely have an impact/change on patient management but would not lead to an adverse outcome for the patient; Category 4: major discrepancy that would impact patient management and lead to adverse outcomes for the patient.

patient's satisfactionAt the end of intervention

Yes/No

Trial Locations

Locations (1)

Lausanne University Hospital

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath